Share this:

Board of Pharmacy Specialties Announces First  

Solid Organ Transplantation Pharmacy Specialty Examination

Registration Opens May 17, 2021


Washington, D.C. – The Board of Pharmacy Specialties (BPS) is pleased to announce the first examination in Solid Organ Transplantation Pharmacy. The registration for the initial exam will open on May 17, 2021 and closes August 3, 2021. The testing window will be open between September 7, 2021 through October 11, 2021.


The petition submitted jointly by the American College of Clinical Pharmacy and the American Society of Health-System Pharmacists defines solid organ transplantation (SOT) pharmacist specialists as follows:

“Solid organ transplantation (SOT) pharmacist specialists have the specialized training and knowledge needed to manage complex medication regimens unique to the SOT population. Additionally, they are experts in meeting clinical and regulatory needs not encountered in any other pharmacy specialty. They care for patients throughout all phases of SOT of all ages, and in various health care settings. SOT pharmacist specialists provide evidence-based, patient-centered medication management. They design, implement, monitor, and modify pharmacotherapeutic plans to improve safety and efficacy, which leads to optimal short-term and long-term patient and allograft outcomes. Core responsibilities of SOT pharmacist specialists are to analyze and reevaluate multifaceted clinical and outcomes data to improve care and demonstrate ongoing quality assessment and process improvement as required by regulatory agencies. Finally, SOT pharmacist specialists are integral members of the interprofessional transplantation team that facilitate medication adherence and pharmacotherapy education.”


The minimum requirements for the Solid Organ Transplantation Pharmacy specialty certification are:

  • Graduation from a pharmacy program accredited by the Accreditation Council for Pharmacy Education (ACPE) or a program outside the U.S. that qualifies the individual to practice in the jurisdiction.
  • A current, active license/registration to practice pharmacy in the U.S. or another jurisdiction.
  • Demonstration of practice experience in one of three ways:

Completion of four (4) years of practice experience** (i.e., four years of experience after licensure/registration as a pharmacist) including 50% or more of that time spent practicing in the domains described in the Solid Organ Transplantation Pharmacy Content Outline


Completion of a PGY1 residency* plus two (2) additional years of practice experience**(i.e., two years of experience after licensure/registration as a pharmacist) including 50% or more of time spent practicing in the domains described in the Solid Organ Transplantation Pharmacy Content Outline


Completion of a specialty (PGY2) residency* in Solid Organ Transplantation Pharmacy; and

  • Achieving a passing score on the Solid Organ Transplantation Pharmacy Specialty Certification Examination.

*Effective January 1, 2013, only residency programs accredited by the American Society of Health-System Pharmacists (ASHP) and completed by the applicant within the past 7 years, or new residency programs granted Candidate Status for accreditation by ASHP are creditable for this purpose.

**Practice experience should be from within the past seven years prior to the application date.


Additional information can be found on the BPS website by clicking here.


About the Board of Pharmacy Specialties

The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA). The mission of BPS is to improve patient care by positioning BPS Board-Certified Pharmacist Specialists as integral members of interprofessional healthcare teams, through recognition and promotion of specialized training, knowledge, and skills for pharmacists in the United States and internationally. Board certification is a recognized credential for determining which pharmacists are qualified to contribute at advanced practice levels given the rigorous standards mandated by BPS board certification and recertification. BPS currently recognizes more than 50,000 active pharmacist certifications across 14 specialties.